Mizuho Maintains Outperform on CVS Health, Raises Price Target to $95

Benzinga · 12/10/2025 14:38
Mizuho analyst Ann Hynes maintains CVS Health (NYSE:CVS) with a Outperform and raises the price target from $88 to $95.